Conserved β-hairpin recognition by the GYF domains of Smy2 and GIGYF2 in mRNA surveillance and vesicular transport complexes

Structure

Volumn 18, Issue 8, 2010, Pages 944-954

  Ash, Miriam Rose ^a   Faelber, Katja ^a   Kosslick, Daniela ^a   Albert, Gesa Ines ^a   Roske, Yvette ^b   Kofler, Michael ^a   Schuemann, Michael ^a   Krause, Eberhard ^a   Freund, Christian ^a  

^a LEIBNIZ INSTITUT FÜR MOLEKULARE PHARMAKOLOGIE   (Germany)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

Cellbio; RNA

Indexed keywords

MESSENGER RNA; PROTEIN; PROTEIN GIGYF2; PROTEIN SMY2; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; CRYSTAL STRUCTURE; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN MOTIF; PROTEIN RNA BINDING; PROTEIN STRUCTURE;

AMINO ACID SEQUENCE; BASE SEQUENCE; CARRIER PROTEINS; CRYSTALLIZATION; ENDOPLASMIC RETICULUM; GOLGI APPARATUS; HELA CELLS; HUMANS; MICROSCOPY, FLUORESCENCE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTEIN STRUCTURE, TERTIARY; RNA PROCESSING, POST-TRANSCRIPTIONAL; SACCHAROMYCES CEREVISIAE; SACCHAROMYCES CEREVISIAE PROTEINS; SEQUENCE ANALYSIS, DNA; TRANSPORT VESICLES; VESICULAR TRANSPORT PROTEINS;

EID: 77955482621     PISSN: 09692126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.str.2010.04.020     Document Type: Article

References (67)

1. Anderson P., Kedersha N. Stress granules: the Tao of RNA triage. Trends Biochem. Sci. 2008, 33:141-150.
2. Awasthi S., Palmer R., Castro M., Mobarak C.D., Ruby S.W. New roles for the Snp1 and Exo84 proteins in yeast pre-mRNA splicing. J. Biol. Chem. 2001, 276:31004-31015.
3. Beggs J.D. Lsm proteins and RNA processing. Biochem. Soc. Trans. 2005, 33:433-438.
4. Beyermann M., Fechner K., Furkert J., Krause E., Bienert M. A single-point slight alteration set as a tool for structure-activity relationship studies of ovine corticotropin releasing factor. J. Med. Chem. 1996, 39:3324-3330.
5. Bialkowska A., Kurlandzka A. Proteins interacting with Lin 1p, a putative link between chromosome segregation, mRNA splicing and DNA replication in Saccharomyces cerevisiae. Yeast 2002, 19:1323-1333.
6. Bras J., Simon-Sanchez J., Federoff M., Morgadinho A., Januario C., Ribeiro M., Cunha L., Oliveira C., Singleton A.B. Lack of replication of association between GIGYF2 variants and Parkinson disease. Hum. Mol. Genet 2009, 18:341-346.
7. Bruno I., Wilkinson M.F. P-bodies react to stress and nonsense. Cell 2006, 125:1036-1038.
8. Budisa N., Steipe B., Demange P., Eckerskorn C., Kellermann J., Huber R. High-level biosynthetic substitution of methionine in proteins by its analogs 2- aminohexanoic acid, selenomethionine, telluromethionine and ethionine in Escherichia coli. Eur. J. Biochem. 1995, 230:788-796.
9. The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D Biol. Crystallgr. 1994, 50:760-763. CCP4 (Collaborative Computational Project, Number 4).
10. Chang W., Zaarour R.F., Reck-Peterson S., Rinn J., Singer R.H., Snyder M., Novick P., Mooseker M.S. Myo2p, a class V myosin in budding yeast, associates with a large ribonucleic acid-protein complex that contains mRNAs and subunits of the RNA-processing body. RNA 2008, 14:491-502.
11. Cosentino G.P., Schmelzle T., Haghighat A., Helliwell S.B., Hall M.N., Sonenberg N. Eap1p, a novel eukaryotic translation initiation factor 4E-associated protein in Saccharomyces cerevisiae. Mol. Cell. Biol. 2000, 20:4604-4613.
12. Davis I.W., Leaver-Fay A., Chen V.B., Block J.N., Kapral G.J., Wang X., Murray L.W., Arendall W.B., Snoeyink J., Richardson J.S., Richardson D.C. MolProbity: all-atom contacts and structure validation for proteins and nucleic acids. Nucleic Acids Res. 2007, 35:W375-W383.
13. Davydenko S.G., Juselius J.K., Munder T., Bogengruber E., Jantti J., Keranen S. Screening for novel essential genes of Saccharomyces cerevisiae involved in protein secretion. Yeast 2004, 21:463-471.
14. Decourty L., Saveanu C., Zemam K., Hantraye F., Frachon E., Rousselle J.C., Fromont-Racine M., Jacquier A. Linking functionally related genes by sensitive and quantitative characterization of genetic interaction profiles. Proc. Natl. Acad. Sci. USA 2008, 105:5821-5826.
15. Deloche O., de la Cruz J., Kressler D., Doere M., Linder P. A membrane transport defect leads to a rapid attenuation of translation initiation in Saccharomyces cerevisiae. Mol. Cell 2004, 13:357-366.
16. Emsley P., Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 2004, 60:2126-2132.
17. Eulalio A., Behm-Ansmant I., Izaurralde E. P bodies: at the crossroads of post-transcriptional pathways. Nat. Rev. Mol. Cell Biol. 2007, 8:9-22.
18. Evans P.R. Scaling and assessment of data quality. Acta. Crystallogr. D. Biol. Crystallogr. 1993, 62:72-82.
19. Freund C., Dotsch V., Nishizawa K., Reinherz E.L., Wagner G. The GYF domain is a novel structural fold that is involved in lymphoid signaling through proline-rich sequences. Nat. Struct. Biol. 1999, 6:656-660.
20. Freund C., Kuhne R., Yang H., Park S., Reinherz E.L., Wagner G. Dynamic interaction of CD2 with the GYF and the SH3 domain of compartmentalized effector molecules. EMBO J. 2002, 21:5985-5995.
21. Frigieri M.C., Thompson G.M., Pandolfi J.R., Zanelli C.F., Valentini S.R. Use of a synthetic lethal screen to identify genes related to TIF51A in Saccharomyces cerevisiae. Genet. Mol. Res. 2007, 6:152-165.
22. Fromont-Racine M., Mayes A.E., Brunet-Simon A., Rain J.C., Colley A., Dix I., Decourty L., Joly N., Ricard F., Beggs J.D., Legrain P. Genome-wide protein interaction screens reveal functional networks involving Sm-like proteins. Yeast 2000, 17:95-110.
23. Gavin A.C., Aloy P., Grandi P., Krause R., Boesche M., Marzioch M., Rau C., Jensen L.J., Bastuck S., Dumpelfeld B., et al. Proteome survey reveals modularity of the yeast cell machinery. Nature 2006, 440:631-636.
24. Georgiev A., Leipus A., Olsson I., Berrez J.M., Mutvei A. Characterization of MYR1, a dosage suppressor of YPT6 and RIC1 deficient mutants. Curr. Genet. 2008, 53:235-247.
25. Georgiev A., Sjostrom M., Wieslander A. Binding specificities of the GYF domains from two Saccharomyces cerevisiae paralogs. Protein Eng. Des. Sel. 2007, 20:443-452.
26. Gilks N., Kedersha N., Ayodele M., Shen L., Stoecklin G., Dember L.M., Anderson P. Stress granule assembly is mediated by prion-like aggregation of TIA-1. Mol. Biol. Cell 2004, 15:5383-5398.
27. Giovannone B., Lee E., Laviola L., Giorgino F., Cleveland K.A., Smith R.J. Two novel proteins that are linked to insulin-like growth factor (IGF-I) receptors by the Grb10 adapter and modulate IGF-I signaling. J. Biol. Chem. 2003, 278:31564-31573.
28. Higashio H., Sato K., Nakano A. Smy2p participates in COPII vesicle formation through the interaction with Sec23p/Sec24p subcomplex. Traffic 2008, 9:79-93.
29. Huh W.K., Falvo J.V., Gerke L.C., Carroll A.S., Howson R.W., Weissman J.S., O'Shea E.K. Global analysis of protein localization in budding yeast. Nature 2003, 425:686-691.
30. Jackson C.L., Kepes F. BFR1, a multicopy suppressor of brefeldin A-induced lethality, is implicated in secretion and nuclear segregation in Saccharomyces cerevisiae. Genetics 1994, 137:423-437.
31. Kalscheuer V.M., Freude K., Musante L., Jensen L.R., Yntema H.G., Gecz J., Sefiani A., Hoffmann K., Moser B., Haas S., et al. Mutations in the polyglutamine binding protein 1 gene cause X-linked mental retardation. Nat. Genet. 2003, 35:313-315.
32. Kay B.K., Williamson M.P., Sudol M. The importance of being proline: the interaction of proline-rich motifs in signaling proteins with their cognate domains. FASEB J. 2000, 14:231-241.
33. Kedersha N., Anderson P. Mammalian stress granules and processing bodies. Methods Enzymol. 2007, 431:61-81.
34. Klemm C., Otto S., Wolf C., Haseloff R.F., Beyermann M., Krause E. Evaluation of the titanium dioxide approach for MS analysis of phosphopeptides. J. Mass Spectrom. 2006, 41:1623-1632.
35. Kofler M., Heuer K., Zech T., Freund C. Recognition sequences for the GYF domain reveal a possible spliceosomal function of CD2BP2. J. Biol. Chem. 2004, 279:28292-28297.
36. Kofler M., Motzny K., Beyermann M., Freund C. Novel interaction partners of the CD2BP2-GYF domain. J. Biol. Chem. 2005, 280:33397-33402.
37. Kofler M., Motzny K., Freund C. GYF domain proteomics reveals interaction sites in known and novel target proteins. Mol. Cell. Proteomics 2005, 4:1797-1811.
38. Kofler M., Schuemann M., Merz C., Kosslick D., Schlundt A., Tannert A., Schaefer M., Luhrmann R., Krause E., Freund C. Proline-rich sequence recognition: I. Marking GYF and WW domain assembly sites in early spliceosomal complexes. Mol. Cell. Proteomics 2009, 8:2461-2473.
39. Kofler M.M., Freund C. The GYF domain. FEBS J. 2006, 273:245-256.
40. Laggerbauer B., Liu S., Makarov E., Vornlocher H.P., Makarova O., Ingelfinger D., Achsel T., Luhrmann R. The human U5 snRNP 52K protein (CD2BP2) interacts with U5-102K (hPrp6), a U4/U6.U5 tri-snRNP bridging protein, but dissociates upon tri-snRNP formation. RNA 2005, 11:598-608.
41. Lang B.D., Li A., Black-Brewster H.D., Fridovich-Keil J.L. The brefeldin A resistance protein Bfr1p is a component of polyribosome-associated mRNP complexes in yeast. Nucleic Acids Res. 2001, 29:2567-2574.
42. Lautier C., Goldwurm S., Durr A., Giovannone B., Tsiaras W.G., Pezzoli G., Brice A., Smith R.J. Mutations in the GIGYF2 (TNRC15) gene at the PARK11 locus in familial Parkinson disease. Am. J. Hum. Genet. 2008, 82:822-833.
43. Leslie A.G.W. Recent changes to the MOSFLM package for processing film and image plate data. Joint CCP4 ESF-EAMCB Newsletter on Protein Crystallography 1992, 26:27-33.
44. Li Y., Moir R.D., Sethy-Coraci I.K., Warner J.R., Willis I.M. Repression of ribosome and tRNA synthesis in secretion-defective cells is signaled by a novel branch of the cell integrity pathway. Mol. Cell. Biol. 2000, 20:3843-3851.
45. Lillie S.H., Brown S.S. Suppression of a myosin defect by a kinesin-related gene. Nature 1992, 356:358-361.
46. McCoy A.J., Grosse-Kunstleve R.W., Adams P.D., Winn M.D., Storoni L.C., Read R.J. Phaser crystallographic software. J. Appl. Crystallogr. 2007, 40:658-674.
47. Mizuta K., Warner J.R. Continued functioning of the secretory pathway is essential for ribosome synthesis. Mol. Cell. Biol. 1994, 14:2493-2502.
48. Murshudov G.N., Vagin A.A., Dodson E.J. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr. D Biol. Crystallogr. 1997, 53:240-255.
49. Musacchio A., Wilmanns M., Saraste M. Structure and function of the SH3 domain. Prog. Biophys. Mol. Biol. 1994, 61:283-297.
50. Nagafuchi S., Yanagisawa H., Ohsaki E., Shirayama T., Tadokoro K., Inoue T., Yamada M. Structure and expression of the gene responsible for the triplet repeat disorder, dentatorubral and pallidoluysian atrophy (DRPLA). Nat. Genet. 1994, 8:177-182.
51. Nelson K.K., Lemmon S.K. Suppressors of clathrin deficiency: overexpression of ubiquitin rescues lethal strains of clathrin-deficient Saccharomyces cerevisiae. Mol. Cell. Biol. 1993, 13:521-532.
52. Nielsen T.K., Liu S., Luhrmann R., Ficner R. Structural basis for the bifunctionality of the U5 snRNP 52K protein (CD2BP2). J. Mol. Biol. 2007, 369:902-908.
53. Nishizawa K., Freund C., Li J., Wagner G., Reinherz E.L. Identification of a proline-binding motif regulating CD2-triggered T lymphocyte activation. Proc. Natl. Acad. Sci. USA 1998, 95:14897-14902.
54. Ong S.E., Blagoev B., Kratchmarova I., Kristensen D.B., Steen H., Pandey A., Mann M. Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol. Cell. Proteomics 2002, 1:376-386.
55. Perrakis A., Morris R., Lamzin V.S. Automated protein model building combined with iterative structure refinement. Nat. Struct. Biol. 1999, 6:458-463.
56. Reijns M.A., Alexander R.D., Spiller M.P., Beggs J.D. A role for Q/N-rich aggregation-prone regions in P-body localization. J. Cell Sci. 2008, 121:2463-2472.
57. Schlundt A., Sticht J., Piotukh K., Kosslick D., Jahnke N., Keller S., Schuemann M., Krause E., Freund C. Proline-rich sequence recognition: II. Proteomics analysis of Tsg101 ubiquitin-E2-like variant (UEV) interactions. Mol. Cell. Proteomics 2009, 8:2474-2486.
58. Sezen B., Seedorf M., Schiebel E. The SESA network links duplication of the yeast centrosome with the protein translation machinery. Genes Dev. 2009, 23:1559-1570.
59. Sheldrick G.M. A short history of SHELX. Acta Crystallogr. A 2008, 64:112-122.
60. Tan E.K., Schapira A.H. Summary of GIGYF2 studies in Parkinson's disease: the burden of proof. Eur. J. Neurol. 2010, 17:175-176.
61. Trautwein M., Dengjel J., Schirle M., Spang A. Arf1p provides an unexpected link between COPI vesicles and mRNA in Saccharomyces cerevisiae. Mol. Biol. Cell 2004, 15:5021-5037.
62. Vaguine A.A., Richelle J., Wodak S.J. SFCHECK: a unified set of procedures for evaluating the quality of macromolecular structure-factor data and their agreement with the atomic model. Acta Crystallogr. D Biol. Crystallogr. 1999, 55:191-205.
63. Vriend G. WHAT IF: a molecular modeling and drug design program. J. Mol. Graph. 1990, 8:52-56. 29.
64. Wang L., Guo J.F., Zhang W.W., Xu Q., Zuo X., Shi C.H., Luo L.Z., Liu J., Hu L., Hu Y.C., et al. Novel GIGYF2 gene variants in patients with Parkinson's disease in Chinese population. Neurosci. Lett. 2010, 473:131-135.
65. Winn M.D., Isupov M.N., Murshudov G.N. Use of TLS parameters to model anisotropic displacements in macromolecular refinement. Acta Crystallogr. D Biol. Crystallogr. 2001, 57:122-133.
66. Zarrinpar A., Bhattacharyya R.P., Lim W.A. The structure and function of proline recognition domains. Sci. STKE 2003, 179:RE8.
67. Zhao R., Davey M., Hsu Y.C., Kaplanek P., Tong A., Parsons A.B., Krogan N., Cagney G., Mai D., Greenblatt J., et al. Navigating the chaperone network: an integrative map of physical and genetic interactions mediated by the hsp90 chaperone. Cell 2005, 120:715-727.